Matteo Giovanni D. P.
- Country
- Italy
- Department
- Unit of Oncology and Hematology
Research Overview
- Evaluation of CC-95251 Monotherapy and in Combination with Antineoplastic Agents in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Evaluation of DFV890 for Safety, Tolerability, and Efficacy in Patients with Myeloid Diseases
- A Phase 2/3, Multicenter, Randomized, Dose Optimization (Part I), Double-blind (Part II) Study to Compare the Efficacy and Safety of Oral Azacitidine (Oral-Aza, ONUREG®) plus Best Supportive Care (BSC) versus Placebo plus BSC in Participants with IPSS-R Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
Data & Insights
Has run more than one trial at 183 of 373 partner sites.
Specializations
Myeloid Disorders
The investigator specializes in treating various forms of myeloid disorders, with particular emphasis on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
- High-risk and low-risk MDS management
- Treatment-resistant myeloid conditions
- Novel therapeutic approaches for AML
Extensive experience in evaluating innovative treatments for both newly diagnosed and relapsed/refractory cases.
Anemia Management
Focuses on treating transfusion-dependent anemia in patients with hematologic disorders, particularly exploring new therapeutic options for lower-risk MDS patients.
- Red blood cell transfusion independence strategies
- Novel erythroid maturation agents
- Hemoglobin optimization approaches
Specializes in developing treatment strategies for patients who are refractory to standard therapies.
Targeted Therapies
Investigates molecular-targeted treatments for hematologic malignancies, including therapies for specific mutations such as IDH1 and FLT3.
- Combination therapy approaches
- Novel drug development
- Mutation-specific treatments
Expertise in evaluating innovative therapeutic combinations and novel treatment mechanisms.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.